Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2026

Go back to Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2026
(NASDAQ: DTIL) Delayed: 6.78 +0.07 (1.04%)
Previous Close $6.71    52 Week High $ 
Open $6.70    52 Week Low $ 
Day High $6.93    P/E N/A 
Day Low $6.58    EPS $ 
Volume 132,429